Evidence map›Paper›PMID 19393580›Full record

ArticleMolecular oncology2009

Neurotensin signaling induces intracellular alkalinization and interleukin-8 expression in human pancreatic cancer cells.

Ulrike Olszewski, Gerhard Hamilton

Open access · bronzeAbstract read
In one paragraph

Article in Molecular oncology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Neurotensin modulates ovarian vascular permeability via adherens junctions.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. (Patho-)Physiology of NaFrontiers in physiology · 2019
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ulrike OlszewskiDepartment of Surgery, Medical University of Vienna, A-1090 Vienna, Austria. u.olszewski@gmx.net
Gerhard Hamilton
Ludwig Boltzmann Institute for Cardiovascular Research · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic adenocarcinomas express neurotensin receptors in up to 90% of cases, however, their role in tumor biology and as a drug target is not clear. In the present study, a stable neurotensin (NT) analog induced intracellular calcium release and intracellular alkalinization in BxPC-3 and PANC-1 pancreatic cancer cells that was abolished by inhibitors of NT receptor (NTR) and sodium-proton exchanger 1 (NHE1), amiloride and SR 142948, respectively. Activation of NHE1 involved increased phosphorylation of dimethylfumarate-sensitive mitogen- and stress-activated kinase 1/2 (MSK1/2). NTR signaling appears to promote a metastatic phenotype in pancreatic cancer cells by induction of localized extracellular acidification in normoxic cells, preceeding acidosis induced by hypoxia and switch to glycolysis in addition to increased expression of interleukin-8 (IL-8).

Indexed as

Gene Expression Regulation, NeoplasticSignal TransductionAdenocarcinomaAmilorideCation Transport ProteinsCell Line, TumorHumansInterleukin-8Neoplasm MetastasisNeoplasm ProteinsNeurotensinPancreatic NeoplasmsPhosphorylationPyrazolesQuinolinesReceptors, NeurotensinAmilorideCation Transport ProteinsCXCL8 protein, humanInterleukin-8mitogen and stress-activated protein kinase 1Neoplasm ProteinsNeurotensinPyrazolesQuinolinesReceptors, NeurotensinRibosomal Protein S6 Kinases, 90-kDaRPS6KA4 protein, humanSLC9A1 protein, humanSodium Channel BlockersSodium-Hydrogen Exchanger 1Sodium-Hydrogen ExchangersSR 142948

Identifiers

PMID19393580
PMCPMC5527856
OpenAlexW1964694538

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.